Duke Capital is a financial services firm that specializes in providing investment banking, asset management, and financial advisory services to individuals, corporations, and institutional clients.

Duke Capital

Previously Duke Royalty.
Duke is a leading provider of hybrid capital solutions for SME business owners in UK, Europe and North America, combining the best features of both equity and debt.

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique ‘corporate mortgage’ while also aligning its returns to grow with the success of the business.

More about our company can be found at www.dukecapital.com

Duke Capital Limited

We are pleased today to announce the successful exit of our investment in Fabrikat (Nottingham) Ltd, a UK manufacturer of street lighting columns and guard rails.
 
This exit delivers an IRR of 36% for the Company, with further potential gains available from future performance-related deferred consideration.
 
Our CEO Neil Johnson said:
 
“Fabrikat is a real success story for Duke and a great case study for why Duke’s capital is a perfect fit for individuals seeking to execute an MBO. Our capital allowed long-standing employees of a strong business to step up into large equity ownership positions and in that role, they continued to prove themselves as great stewards of the business, creating value for all stakeholders. In turn, we are pleased to build on our already robust track record of achieving above-average returns on exits.”
 
Read more details here: https://lnkd.in/e3qmXNTe
 
If you would like to learn more about Fabrikat (Nottingham) Ltd’s story, you can view the full video here: https://lnkd.in/ehMMJDta

 
#DukeCapital #PrivateCredit #HybridFinance #HybridCapital #londonstockexchange #CEO #MBO

We are pleased today to announce the successful exit of our investment in Fairmed Healthcare AG. 
 
With a headline cash consideration of €11.4 million, it provides us with additional liquidity for new deployments into our pipeline of long-established, profitable businesses. This represents the seventh exit for the Company, delivering a sixth profitable exit.
 
Our CEO Neil Johnson said:
 
“We are proud to have supported Fairmed during a crucial time in the development of its product portfolio. Our capital injection empowered its management team to achieve their strategic objectives without burdening the business with loss of control or refinancing risk, underscoring our commitment to facilitating growth and success for our partners. 
 
“We are pleased to build on our track record of successfully delivering profitable exits and are excited to see Fairmed and Strides deliver on the next phase of their European strategy. We look forward to continuing to deploy capital into other promising opportunities.”          
 
Read more details below:
 
#DukeCapital #PrivateCredit #HybridFinance #HybridCapital #londonstockexchange #CEO 

We are pleased today to announce that we have increased our equity stake in United Glass Group (UGG) from 30.0% to 73.8% through a £2.9 million secondary share purchase from existing shareholders.
 
This investment aligns with the Company’s vision to deepen our engagement with our high-performing portfolio companies, reaffirming our confidence in UGG’s potential for sustained success.

Our CEO Neil Johnson said:
 
“We have been invested in UGG since 2018 and during this time the Company has achieved significant growth and proven itself to be a highly successful partner. Their long-standing track record and strong potential for future growth means that it makes perfect sense to increase our equity stake in the business.”

Read more details below:
 
#DukeCapital #PrivateCredit #HybridFinance #HybridCapital #UnitedGlassGroup #UGG

Metric
Company Name	Duke Capital
Symbol
MSH ID	COM:DUKECAPITAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Financial Services
Country	GG
Stage
Employee Count	13
Website	dukecapital.com
LinkedIn	duke-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DUKECAPITAL

Duke Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue